Pharmaceutical solutions of levosimendan
AssigneeOrion Corporation
InventorsReijo Bäckström, Päivi Granvik, Ritva Haikala, Sirpa Pelttari, Eva Saukko, Reija Yrjölä
Life of this patent
Estimating the term…
Abstract
Levosimendan solutions for pharmaceutical use, and particularly for intravenous administration. The solutions of the invention have enhanced stability and they are particularly useful as infusion or injection solutions or infusion concentrates. Levosimendan is useful in the treatment of congestive heart failure.
Claims14
An aqueous intravenous infusion solution comprising levosimendan or a salt thereof as an active ingredient, the pH-value of the solution being lower than 5, and a solubility enhancing agent, wherein the solubility enhancing agent is polyvinylpyrrolidone or ethanol.
A pharmaceutical solution, comprising
- (a) levosimendan or a pharmaceutically acceptable salt thereof as an active ingredient,
- (b) a pharmaceutically acceptable organic solvent comprising ethanol,
- (c) a stability enhancing amount of a pharmaceutically acceptable organic acid having pKa in the range of from 2 to 4, and optionally
- (d) a water-solubility enhancing agent.
Dependencies are inferred from the claim text.